ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,975Medicare Part D Prescriptions Filled, Including Refills

Rank: 812 out of 2888

$495K Total Retail Price of All Prescriptions

Rank: 856 out of 2888

565 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,196 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
METOPROLOL TARTRATE 243 187 1 10
LISINOPRIL 239 189 2 3
LEVOTHYROXINE SODIUM 237 201 3 1
AMLODIPINE BESYLATE 208 176 4 5
SIMVASTATIN 204 158 5 2
METFORMIN HCL 198 104 6 8
OMEPRAZOLE 182 156 7 7
FUROSEMIDE 169 136 8 6
LOVASTATIN 153 116 9 41
HYDROCODONE-ACETAMINOPHEN 151 91 S3 10 4
METOPROLOL SUCCINATE 141 107 11 11
ALENDRONATE SODIUM 139 111 12 23
HYDROCHLOROTHIAZIDE 137 117 13 15
AZITHROMYCIN 135 93 14 38
TRAMADOL HCL 123 102 15 16
TAMSULOSIN HCL 120 105 16 29
NEXIUM 118 88 17 19
LOSARTAN POTASSIUM 106 90 18 18
CEFDINIR 104 69 19 194
LEVOFLOXACIN 102 78 20 57
JANUVIA 97 53 21 48
ATORVASTATIN CALCIUM 91 68 22 9
CLOPIDOGREL 89 77 23 30
ZOLPIDEM TARTRATE 87 70 24 17
POTASSIUM CHLORIDE 86 73 25 14
PANTOPRAZOLE SODIUM 83 54 26 33
WARFARIN SODIUM 78 76 27 22
GLYBURIDE 78 46 R 27 58
ATENOLOL 75 59 29 25
DIOVAN 74 74 30 35
NAMENDA 74 74 30 34
CRESTOR 69 50 32 20
FAMOTIDINE 67 60 33 75
ESCITALOPRAM OXALATE 65 50 34 62
PHENYTOIN SODIUM EXTENDED 64 48 35 128
CIPROFLOXACIN HCL 62 51 36 47
PLAVIX 59 51 37 40
PRAVASTATIN SODIUM 58 51 38 12
ISOSORBIDE MONONITRATE ER 58 41 38 51
IBUPROFEN 56 44 40 87
GLYBURIDE-METFORMIN HCL 56 45 R 40 64
ENALAPRIL MALEATE 54 39 42 49
DIOVAN HCT 53 48 43 61
LYRICA 53 49 43 69
CITALOPRAM HBR 51 36 45 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.